Baxter: FDA 510(k) clearances across all its applicant names

FDA lists 822 510(k) clearances, 5 PMA and 1 De Novo decisions across the 23 applicant names Caduvo groups under Baxter, first 1977, latest 2026. Median 510(k) review time across these names: 86 days. Since 2017 the median was 134 days, against 148 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

510(k) clearances per year

YearClearancesMedian review days
20121054
20131242
201414100
2015873
20167164
20177106
20188170
20191298
20201072
20219179
202213195
2023786
20247217
20257142
20264242

The 23 FDA applicant names in this group

Applicant name510(k) clearancesPMADe NovoYears
Baxter Healthcare Corp568511977–2025
Welch Allyn, Inc.112001977–2025
Mortara Instrument, Inc.51001983–2019
Hill-Rom, Inc.37001986–2026
Synovis Life Technologies, Inc.9002013–2023
Bardy Diagnostics, Inc.7002014–2023
Welch Allyn Protocol, Inc.7002001–2007
Allen Medical Systems, Inc.5001993–1997
Hill-Rom Services Pte, Ltd.5002013–2020
Hill-Rom Manufacturing, Inc.4002002–2008
Baxter Healthcare Corportation3002020–2024
Baxter/ Synovis Micro Companies Alliance, Inc.2002019–2019
Synovis Life Technologies, Inc. (Baxter International Inc.)2002019–2026
Baxter Corp.1001994–1994
Baxter Healthcare Corp/ Excel Medical1002026–2026
Baxter Healthcare Corproration1002022–2022
Baxterhealthcare, Inc.1002007–2007
Hill-Rom Holdings, Inc.1002018–2018
Hill-Rom Services Private Limited1002015–2015
Mrl, A Welch Allyn Company1002004–2004
Synovis Life Technologies. Inc. (A Subsidiary of Baxter1002021–2021
Synovis Micro Companies Alliance A Subsidiary of Baxter Int1002025–2025
Videomed Srl ( a Baxter Healthcare Corp company)1002026–2026

Review time against the same product codes

Since 2017, 510(k)s cleared under these names took a median 134 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 148 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
FPASet, Administration, Intravascular6767
FRNPump, Infusion5353
KDIDialyzer, High Permeability With Or Without Sealed Dialysate System2727
DPSElectrocardiograph2525
KDJSet, Administration, For Peritoneal Dialysis, Disposable1616
MWIMonitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)1515
DXNSystem, Measurement, Blood-Pressure, Non-Invasive1313
LHISet, I.V. Fluid Transfer1212
JJYMulti-Analyte Controls, All Kinds (Assayed)1010
MQVFiller, Bone Void, Calcium Compound1010

Plus 265 more product codes.

Review panels

Most recent Baxter 510(k) clearances

510(k)DeviceApplicant nameProduct codeDecision dateReview days
K260431Dura-Guard Dural Repair PatchSynovis Life Technologies, Inc. (Baxter International Inc.)GXQ2026-11-05282
K260211Dashboard (P007000)Hill-Rom, Inc.MSX2026-08-13202
K254265Helion Viewer SuiteVideomed Srl ( a Baxter Healthcare Corp company)LLZ2026-05-27148
K250135WAVE Clinical Platform (2.0.000)Baxter Healthcare Corp/ Excel MedicalMWI2026-01-16364
K251745Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs)Baxter Healthcare CorpDXQ2025-12-16193
K251640SIGMA Spectrum Infusion Pump with Master Drug LibraryBaxter Healthcare CorpFRN2025-07-2860
K251636Spectrum IQ Infusion System with Dose IQ Safety Software (3570009)Baxter Healthcare CorpFRN2025-07-2860
K243598Welch Allyn Connex® 360 (Multiple)Welch Allyn, Inc.—2025-07-13234
K243529Solution Administration SetsBaxter Healthcare CorpFPA2025-03-14120
K242339Intravascular Extension Sets and AccessoriesBaxter Healthcare CorpFPA2025-02-28205

812 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P210036PMAPerClot® Polysaccharide Hemostatic System2023-05-19
DEN190042De NovoHemodialyzer With Expanded Solute Removal Profile2020-08-28
P100030PMAARTERX SURGICAL SEALANT2013-03-01
P050011PMAADEPT (4% ICODEXTRIN) ADHESION REDUCTION SOLUTION2006-07-28
P990009PMAFLOSEAL MATRIX/FLOSEAL MATRIX HEMOSTATIC SEALANT/PROCEED HEMOSTATIC SEALANT1999-12-08

Recalls

921 product recalls in 419 recall events under these names; 287 initiated in the last five years.

107 product recalls in 66 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 10 initiated in the last five years. Most often: Baxter Healthcare Renal Div (40), Beckman Coulter Inc. (10), WELCH ALLYN, INC/MORTARA (8).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

ClinicalTrials.gov lists 59 device studies (1 active or recruiting) with an industry lead sponsor under the 4 sponsor names below. Most recent:

Lead sponsor name on ClinicalTrials.govDevice studies
Baxter Healthcare Corporation34
Hill-Rom20
Welch Allyn3
Mortara Instrument2

Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.

Parent company SEC filings

BAXTER INTERNATIONAL INC (BAX): EDGAR filings, CIK 10456. The parent's SEC registrant is entered by hand for this group, not matched by name.

How this group is built

Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

Hill-Rom (December 2021; incl. Welch Allyn 2015, Mortara 2017, Bardy Diagnostics 2021) and Synovis (2012). Includes filings made before each acquisition. Left out: Kidney Care (Gambro, renal division) — sold to Carlyle as Vantive on January 31, 2025; the main BAXTER HEALTHCARE name still contains pre-2025 renal filings that cannot be split out. Also left out: Baxter Diagnostics (became Dade, now Siemens Healthineers), Baxter Edwards (now Edwards Lifesciences), BioScience (Baxalta/Takeda), Travenol-era names (mixed businesses later divested).

Sources

Frequently asked questions

How many FDA 510(k) clearances are listed across Baxter's applicant names?

FDA lists 822 510(k) clearances, 5 PMA and 1 De Novo decisions across the 23 applicant names Caduvo groups under Baxter, first 1977, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.

Which FDA applicant names does Baxter file under?

The names with the most 510(k) clearances in this group are Baxter Healthcare Corp (568); Welch Allyn, Inc. (112); Mortara Instrument, Inc. (51); Hill-Rom, Inc. (37); Synovis Life Technologies, Inc. (9). The full list of 23 names is on this page.

How long does FDA take to clear Baxter 510(k)s?

The median time from FDA receipt to decision across 510(k)s cleared under these names is 86 days. Since 2017 the median was 134 days, against 148 days for all cleared 510(k)s in the same product codes.

Does the Baxter count include acquired companies?

Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.

How many device clinical trials does Baxter sponsor?

ClinicalTrials.gov lists 59 device studies (1 active or recruiting) with an industry lead sponsor under 4 sponsor names Caduvo groups under Baxter. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.

All parent companies · FDA device companies by applicant name · FDA product code lookup